Effectiveness of ChatGPT 4.0 in Telemedicine-Based Management of Metastatic Prostate Carcinoma.

Publication date: Aug 29, 2024

The recent rise in telemedicine, notably during the COVID-19 pandemic, highlights the potential of integrating artificial intelligence tools in healthcare. This study assessed the effectiveness of ChatGPT versus medical oncologists in the telemedicine-based management of metastatic prostate cancer. In this retrospective study, 102 patients who met inclusion criteria were analyzed to compare the competencies of ChatGPT and oncologists in telemedicine consultations. ChatGPT’s role in pre-charting and determining the need for in-person consultations was evaluated. The primary outcome was the concordance between ChatGPT and oncologists in treatment decisions. Results showed a moderate concordance (Cohen’s Kappa = 0. 43, p < 0. 001). The number of diagnoses made by both parties was not significantly different (median number of diagnoses: 5 vs. 5, p = 0. 12). In conclusion, ChatGPT exhibited moderate agreement with oncologists in management via telemedicine, indicating the need for further research to explore its healthcare applications.

Open Access PDF

Concepts Keywords
Basel artificial intelligence
Cancer ChatGPT
Healthcare metastatic prostate cancer
Intelligence telemedicine
Prostate virtual clinic

Semantics

Type Source Name
disease MESH Carcinoma
disease MESH COVID-19 pandemic
disease MESH prostate cancer
pathway KEGG Prostate cancer
drug DRUGBANK Methionine
disease IDO role
drug DRUGBANK D-Alanine
disease MESH chronic conditions
drug DRUGBANK Coenzyme M
disease MESH malignancies
drug DRUGBANK Trestolone
disease MESH metastasis
disease IDO process
disease MESH complications
disease IDO algorithm
disease MESH hypertension
disease MESH hyperlipidemia
disease MESH gastroesophageal reflux
disease MESH Diabetes Mellitus
disease MESH Depression
disease MESH Atrial Fibrillation
disease MESH Heart Failure
drug DRUGBANK Saquinavir
disease MESH burnout
disease MESH aids
disease IDO entity
drug DRUGBANK Spinosad
disease MESH privacy
disease MESH emergencies
pathway REACTOME Metabolism
drug DRUGBANK Tricyclazole

Original Article

(Visited 3 times, 1 visits today)